Metyrapone
In the US, Metyrapone (metyrapone systemic) is a member of the following drug classes: adrenal corticosteroid inhibitors, in vivo diagnostic biologicals and is used to treat Diagnosis and Investigation.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V04CD01
CAS registry number (Chemical Abstracts Service)
0000054-36-4
Chemical Formula
C14-H14-N2-O
Molecular Weight
226
Therapeutic Categories
Adrenocorticostatic agent
Diagnostic agent: Pituitary function
Chemical Name
1-Propanone, 2-methyl-1,2-di-3-pyridinyl-
Foreign Names
- Metyraponum (Latin)
- Metyrapon (German)
- Métyrapone (French)
- Metirapona (Spanish)
Generic Names
- Metyrapone (OS: USAN, JAN, BAN)
- Methopyrapone (IS)
- Su 4885 (IS)
- Metyrapone (PH: BP 2011, JP XV, USP 34)
Brand Names
- Metopiron
Medius, Switzerland; Novartis, Japan - Metopirone
Alliance, United Kingdom; Alliance, Malta; IFET, Greece; Novartis, Australia; Novartis, Ireland; Novartis, Israel; Novartis, New Zealand; Novartis, United States - Métopirone
HRA, France
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
